Gyre Therapeutics Inc Annual Shareholders Meeting Transcript

Jun 10, 2026 / 05:00PM GMT

Release Date Price: $5.95 (-2.94%)

Transcript

Operator

Welcome to the Annual Meeting for Gyre Therapeutics, Incorporated.

Our host for today's call is Ying Luo, Chief Executive Officer of Gyre and Chair of today's meeting.

I will now turn the call over to your host.

Ying Luo

Gyre Therapeutics Inc - President, Chief Executive Officer, Director

Hello and welcome to Gyre Therapeutics' 2026 Annual Meeting of Shareholders.

My name is Ying Luo, Gyre's Chief Executive Officer, a Member of the Board of Directors, and the Chair of today's meeting. Thank you, all, for joining us today.

Let me begin by introducing the other members of our Board of Directors: Ping Zhang, Chairman of our board; Dr. Gordon Carmichael; Dr. David Epstein; Dr. Renate Parry; Rodney Nussbaum; and Dr. Dan Weng.

I would also like to introduce the other members of the management team who are joining us today: Thomas Eastling, Chief Financial Officer; Josh Bergmann, General Counsel and the Corporate Secretary; and Dr. Yue Xiong, Chief Scientific Officer.

Additionally, Representatives of our

Already have an account? Log in

Get the full story

Subscribe Now

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

30-Day 100% money back guarantee

Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.